Medibank Private Ltd
ASX:MPL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.41
4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Medibank Private Ltd
Medibank Private Ltd
Net Issuance of Debt
Medibank Private Ltd
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medibank Private Ltd
ASX:MPL
|
Net Issuance of Debt
-AU$50m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Generation Development Group Ltd
ASX:GDG
|
Net Issuance of Debt
-AU$888k
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
NobleOak Life Ltd
ASX:NOL
|
Net Issuance of Debt
-AU$577k
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
NIB Holdings Ltd
ASX:NHF
|
Net Issuance of Debt
AU$12.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medibank Private Ltd
Glance View
Medibank Private Ltd., founded in 1976, has established itself as one of Australia’s leading health insurance providers, servicing millions of customers with a commitment to proactive healthcare and comprehensive policies. Initially created as a government initiative to offer affordable health coverage, the company transitioned to a publicly-listed entity in 2014. Medibank operates through two main divisions: Medibank for health insurance and ahm, which primarily targets budget-conscious consumers seeking value-driven options. The firm prides itself on its customer-centric approach, focusing on empowering members through digital health solutions and preventative care initiatives that emphasize wellness, not just illness. For investors, Medibank represents a unique opportunity within the healthcare sector, illustrating stable growth backed by a solid market presence and a loyal customer base. The company navigated the challenges posed by the pandemic adeptly, showcasing resilience as it adapted to changing consumer needs and regulatory landscapes. With an eye toward future profitability, Medibank continues to innovate, investing in technology and partnerships that enhance its service offerings. Its robust financial performance, characterized by consistent revenue generation and a solid dividend payout history, positions it as a reliable investment within the increasingly important health insurance landscape in Australia.
See Also
What is Medibank Private Ltd's Net Issuance of Debt?
Net Issuance of Debt
-50m
AUD
Based on the financial report for Jun 30, 2024, Medibank Private Ltd's Net Issuance of Debt amounts to -50m AUD.
What is Medibank Private Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
-11%
Over the last year, the Net Issuance of Debt growth was -26%. The average annual Net Issuance of Debt growth rates for Medibank Private Ltd have been -11% over the past three years .
You don't have any saved screeners yet
